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Background
Innate responses are key determinants of the outcome of
HIV infection, influencing critical events in the earliest
stages of infection. Innate antiviral immune defenses are
triggered through the recognition of conserved pathogen
associated molecular pattern (PAMP) motifs within viral
products by intracellular pattern recognition receptor
(PRR) proteins in infected cells. Type I interferons (IFN a
and beta) are induced directly in response to viral infec-
tion, resulting in an antiviral state for the cell.
Methods
A ligand independent constitutively active form of PRR
adaptor protein (‘super-PRR’) was constructed and tested
for antiviral properties. NF-kb and IFN production by con-
struct was tested by Luciferase reporter assays. The con-
struct was transfected into RAW 264.7 cells, analyzed for
surface markers and inflammatory cytokines. RT-PCR was
performed to analyze the expression of cytokine/chemo-
kine genes. TZM-bl cells were transfected with plasmid
expressing ‘super-PRR’, infected with HIV-BaL virus and
beta-galactosidase activity was measured.
Results
The constitutively active ‘super-PRR’ generated 50-fold
and 10-fold increase in NF-kb and IFN-beta production
respectively as compared to vector alone. There was signif-
icant increased expression of CD80, CD86, CD40, CCR7,
HLA-DR, secretion of IL-1beta, IL-6, TNF-a and expres-
sion of RANTES, MIP-1beta, IP-10 on transfected RAW
cells. TZM-bl cells transfected with ‘super-PRR’ after
infection with HIV-Bal virus showed significantly reduced
replication of virus. In a transwell experiment, 293T cells
transfected with the ‘super-PRR’ was sufficient to
significantly reduce HIV-1 infection of TZM-bl cells, sug-
gesting soluble factors are involved.
Conclusion
This constitutively active form of PRR adapter protein
induced potent anti-viral innate immune response and
prevented infection with HIV. The modulation of innate
immunity has potential as a powerful strategy to comple-
ment traditional approaches to HIV therapy by protecting
cells from viral infection. We are currently constructing
lentiviral vector vaccines encoding this ‘super-PRR’ as a
method to target this anti-viral response to the site of
HIV-1 Infection.
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